GLENMARK PHARMACEUTICALS
Back to Cashflow Statement
|
GLENMARK PHARMACEUTICALS Last 5 Year Cash Flow from Operating Activities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Cash Flow from Operating Activities | ₹-265 Cr | ₹625 Cr | ₹1,109 Cr | ₹1,131 Cr | ₹1,392 Cr |
What is the latest Cash Flow from Operating Activities ratio of GLENMARK PHARMACEUTICALS ?
Year | Cash Flow from Operating Activities |
---|---|
Mar2024 | ₹-265 Cr |
Mar2023 | ₹625 Cr |
Mar2022 | ₹1,109 Cr |
Mar2021 | ₹1,131 Cr |
Mar2020 | ₹1,392 Cr |
How is Cash Flow from Operating Activities of GLENMARK PHARMACEUTICALS Trending?
Years | Cash Flow from Operating Activities | % Change | |
---|---|---|---|
Mar2024 | ₹-265 Cr | Negative | |
Mar2023 | ₹625 Cr | -43.59 | |
Mar2022 | ₹1,109 Cr | -1.99 | |
Mar2021 | ₹1,131 Cr | -18.76 | |
Mar2020 | ₹1,392 Cr | - |
Compare Cash Flow from Operating Activities of peers of GLENMARK PHARMACEUTICALS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
GLENMARK PHARMACEUTICALS | ₹40,999.4 Cr | -3.9% | -9.7% | 57.2% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹416,692.0 Cr | -5.3% | -7.8% | 24.1% | Stock Analytics | |
DIVIS LABORATORIES | ₹149,215.0 Cr | -3.9% | -7.9% | 51% | Stock Analytics | |
CIPLA | ₹115,000.0 Cr | -1.9% | -6.9% | 3.6% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹98,616.4 Cr | -8.3% | -14.9% | 0.8% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹93,841.4 Cr | -5.7% | -4% | 23.6% | Stock Analytics |
GLENMARK PHARMACEUTICALS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
GLENMARK PHARMACEUTICALS | -3.9% |
-9.7% |
57.2% |
SENSEX | 0.2% |
-2.2% |
7.7% |
You may also like the below Video Courses